• Research/Demonstration Projects: There are no planned or ongoing trials or demonstration projects of PrEP in Zambia. However, PrEP was included in the PEPFAR country operational plan (COP) targets for 2017.
  • Drug Registration: Truvada is registered as treatment. Gilead submitted an application for Truvada as PrEP to Zambia’s regulatory authority, and is awaiting approval.
  • Policy/Regulatory: Oral PrEP is included in Zambia’s Consolidated Guidelines for Treatment and Prevention of HIV Infection, published in late 2016 by the Ministry of Health. Find details on Zambia’s PrEP-related recommendations on pages 23-24.
  • Advocacy: Civil society has voiced the need for Zambia to explore what role PrEP could play in their combination prevention package. Civil society continues to push government and there are current efforts by civil society for PrEP to be included in DREAMS and for demonstration projects to be considered among young women, sero discordant couples and sex workers. Read Pre-Exposure Prophylaxis for Prevention of HIV Infection.

Last updated on September 1, 2017.

News Spotlight